GLP-4TE Active Phase 2 by DesBio

GLP-4TE Active Phase 2 continues the multi-pathway signaling work of Phase 1 through the 1M and 10M ascending potency sequence — supporting ongoing communication across appetite, satiety, insulin, leptin, and central neuroendocrine networks as patients progress toward their weight goal. Phase 1 activates the signaling environment. Phase 2 deepens it — supporting continued metabolic signaling, appetite regulation, and emotional identity shift as patients progress further toward their weight goal. Phase 2 continues the same non-stimulant, non-suppression approach — supporting the body's own appetite, satiety, and metabolic regulatory signals at the deeper 1M and 10M potency levels. Phase 2 addresses what clinicians encounter mid-protocol: patients with more weight to lose, shifting emotional terrain, and nutritional needs that extend beyond the Phase 1 timeline. Supports continued appetite and satiety signaling pathways Assists ongoing metabolic adaptation during active weight change Supports neuroendocrine communication related to energy balance Supports identity and esteem shifts accompanying continued weight change Supports preservation of lean tissue during continued caloric recalibration